Business · 13/10/2015Updated: 10/17/2026 · 1 min read
Organon USA Inc. et al.; FDA Withdraws Approval of 67 New Drug Applications and 128 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn approval of 67 new drug applications and 128 abbreviated new drug applications from multiple applicants, following written notifications from the applicants that the drug products were no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →